Statistics

Total Visits

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial64

Select a period of time:

Number of views in the range

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial14

Views

Views
October 20251
November 20250
December 20250
January 20262
February 20260
March 20269
April 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
Turkey2
Argentina1
Brazil1
Chile1
Ethiopia1
Italy1
Morocco1
Mexico1
Tunisia1
 

Top cities views

Views
Addis Ababa1
Carate Brianza1
Casablanca1
Cunupia1
Del Viso1
Konya1
Montevideo1
Praia Grande1
Santiago1
Tunis1